![]() |
|
|
Vol. 283, Issue 1, 1-6, 1997
Physiologisch-chemisches Institut der Universität, D-72076
Tübingen, Germany
CCl4-induced cirrhosis of rats was used for studying the
influence of L-ornithine-L-aspartate (OA) on
hyperammonemia. OA given to cirrhotic rats (2 g/kg daily) for 2 wk
slightly increased net body weight and led to a significant increase in
plasma urea levels and a decrease in plasma ammonia levels. Serum
concentrations of glutamate, glutamine and arginine decreased
significantly. In the livers of the OA-treated rats the activities of
carbamoylphosphate synthetase I and arginase increased by 30 and 40%,
respectively, approaching normal levels. No change in the activities of
the other urea cycle enzymes as well as of glutamate dehydrogenase, glutaminase and glutamine synthetase was found. The negative
correlation between glutamine synthetase activity and plasma ammonia
levels reported previously for cirrhotic rats (Gebhardt and Reichen, Hepatology 20:684-691, 1994) was corroborated for cirrhotic
animals not treated with OA, but was no longer apparent in OA-treated cirrhotic rats. Despite this improvement, plasma ammonia levels still
varied considerably reflecting the variable accessibility and
activities of glutamine synthetase in cirrhotics. Cultured hepatocytes
from the two groups of rats showed a similar stimulation of urea
production by addition of ammoniumacetate and/or OA to Hanks' buffered
salt solution. In Williams medium E, however, the hepatocytes from the
OA group produced significantly more urea than those from controls.
These results suggest that treatment of cirrhotic rats with OA
considerably improves urea production favoring the detoxification of
ammonia that, however, is still limited by the severe alterations in
liver architecture that are not influenced by OA in a 2-wk period.
This article has been cited by other articles:
![]() |
J. D. Klein, P. Rouillard, B. R. Roberts, and J. M. Sands Acidosis Mediates the Upregulation of UT-A Protein in Livers from Uremic Rats J. Am. Soc. Nephrol., March 1, 2002; 13(3): 581 - 587. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Jobin and R. B. Sartor The Ikappa B/NF-kappa B system: a key determinant of mucosal inflammation and protection Am J Physiol Cell Physiol, March 1, 2000; 278(3): C451 - C462. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Jobin, C. A. Bradham, M. P. Russo, B. Juma, A. S. Narula, D. A. Brenner, and R. B. Sartor Curcumin Blocks Cytokine-Mediated NF-{kappa}B Activation and Proinflammatory Gene Expression by Inhibiting Inhibitory Factor I-{kappa}B Kinase Activity J. Immunol., September 15, 1999; 163(6): 3474 - 3483. [Abstract] [Full Text] [PDF] |
||||